1.
|
Phase: Phase IV Type: Prevention Status: Active Age: 55 and over Sponsor: NCI, Other Protocol IDs: ROI10-352, R01CA138627, NCT01296672
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 21 to 70 Sponsor: Other Protocol IDs: OSU-09105, NCI-2011-03180, NCT01692340
|
|
3.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 40 to 80 Sponsor: NCI Protocol IDs: NCI-2012-00085, I 182210, CDR0000717828, NU-NWU09-4-03, NWU09-4-03, NCT01497431
|
|
4.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UIC-2004-0217, NCT00322114
|
|
5.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 20 to 60 Sponsor: Other Protocol IDs: 07/09/VA18, NCT00562341
|
|
6.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 20 to 79 Sponsor: Other Protocol IDs: PSHCI 08-012, NCT01112449
|
|
7.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: Portland VA-09-0607, 2096, 6232, 2PO1CA090890-06A2, NCT01265953
|
|
8.
|
Phase: No phase specified Type: Prevention Status: Active Age: 21 to 60 Sponsor: Other Protocol IDs: 0220100243, NCT01611038
|